Dimethyl
TECFIDERA
NADAC/unit
$0.5181
No Shortage
Tier 1: 48.9%
PA Req: 186.0%
13 Manufacturers
26 ANDAs
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and a....
vs. brand TECFIDERA: Generic saves up to 95% per unit
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAMNEAL EU LTDAUROBINDO PHARMA LTDBIOGEN INCGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT IIILUPIN INCMACLEODS PHARMACEUTICALS LTDMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCPRINSTON PHARMACEUTICAL INCSOLA PHARMACEUTICALSTWI PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.